NCPA January 20, 2021
The Community Pharmacy Innovation in Quality Awards recognize individual practitioners and innovative community pharmacy practices that result in improvements in quality of care, medication optimization, and patient outcomes. Presented by the Pharmacy Quality Alliance, the awards are supported by funding from the Community Pharmacy Foundation. You do not have to be a member to make a nomination or win an award. Individuals may nominate themselves, their organizations, or others through Feb. 1. Click here for more information and a nomination form.
NCPA
TEDx Event Celebrates Role of Pharmacists During COVID-19 Pandemic pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.
The Pharmacy Quality Alliance recently announced its endorsement of two diabetes-focused health plan performance measures.
First up is the Use of Medications to Prevent Major Cardiovascular Events in Persons with Diabetes measure, which evaluates the percentage of individuals over the age of 18 years old who have Type 2 diabetes and an established atherosclerotic cardiovascular disease and were prescribed a GLP-1 receptor agonist or SGLT-2 inhibitor with proven cardiovascular benefit during the measurement year.
The second measure is the Persistence to Basal Insulin, which evaluates the percentage of those over the age of 18 years old who were on treatment persistent to basal insulin during the measurement year.
Managing Editor
The first vaccine to prevent COVID-19 has been cleared for use in the United States. The Food and Drug Administration on Saturday granted emergency use authorization to Pfizer and BioNTech’s COVID-19 vaccine for use in individuals 16 years old and older. The first shipments began leaving facilities on Sunday.
The FDA’s decision was based on data from its Phase 3 clinical study, whose results were published last week in the New England Journal of Medicine and which saw a 95% vaccine efficacy rate. The two companies continue to gather additional data and prepare a biologics license application for full approval from the FDA in 2021.
Share this article
Share this article
WASHINGTON, Dec. 11, 2020 /PRNewswire/ The leaders of 18 pharmacy organizations today issued the following statement following the Food and Drug Administration s approval of the first Emergency use Authorization for the COVID-19 vaccine. We heartily welcome the decision by the US Food and Drug Administration (FDA) to authorize the emergency use of the first COVID-19 vaccine, following the recommendation of the Vaccines and Related Biological Products Advisory Committee (VRBPAC). This is a historic moment in the nation s effort to end the pandemic. The pharmacy profession is ready to do its part as qualified, active participants in administering these vaccines in accordance with guidance issued by the FDA, CDC, HHS and state and local health departments, as well as increasing access for the American public to these important disease prevention tools.